Institution Sales Manager
Tabuk
Total years of experience :17 years, 4 Months
Responsible for creation and Management of the new business unit of Institution at Tabuk in Central East Area
•Responsible for the whole company portfolio of introduction of strategic and liquidation of non-strategic products.
•Leading 6 Medical representatives.
•Managing and leading setting a clear introduction plan for products in the main institution in the kingdom and liquidation of the available products by setting clear strategic 1:1 sales calls
•Planning for all the operational expenses and managing its distribution
•Engagement for Top Thought Leaders customers by setting a planned visits
•Leading a diverse of 8 highly performing representatives that can execute and achieve our sales plan and goals
•Provides leadership through coaching, motivation, direction, delegation and development
•Managing, Forecasting, and depleting through people the awarded quantity of the MOH tenders and Major Institution tenders in Central East Territory with small retail territory
•Identifying and building strong relationship with key thought leaders
•Excellent relation with all the decision makers in the pharmacy and planning departments all over the central east area in the major and minor accounts
•Support hiring activities and early identification of talents
•Provide day to day supervision of all sales activities
•Setting a clear 90 days action plan/Sales Rep/Account
•Effectively manage and control expenses to maximize the return of investment
•Monthly arrangement of developmental sales meeting to review situation/Account and monitor sales rep developmental plan process
•Leading the team to implement Marketing strategy effectively
•Working with cross functional team to maximize business success
•Involved in the launch and prelaunch activities of (Straterra-Cymbalta-Zyprexa IM)
•Maximized the growth of zyprexa (olanzapine) to be a market leader in MOH sector and Achieved 40% growth for zyprexa in 2012 over 2013
•Responsible for 12, 000, 000 USD total plan for Central East Area
•Secured 42, 000, 000 for total line in SGH tender by outstanding relation and excellent lobby between the hospitals and the central medical supplies reflected in excellent quantity raised created from
•massive consumption and liquidation of stocks at the main and peripheral hospital
•Always review compliance policy to make sure that there is no deviation and setting a clear corrective measures whenever needed
On Job Assignments and projects 2011-2012
• Sales Force Access Capabilities development
• How to manage a Champion
On Job Assignments 2009-2011
• Responsible for the onboarding training sections for institution and MOH awareness and access in Eli Lilly initial development program to the fresh employee
• Central province Riyadh, Gassim, Arar, Hail and Al Jouf.
• Zyprexa: (Olanzapine) 10mg Tab and 5mg Tab, 10 mg Inj.for treatment of schizophrenia and bipolar disorder
• Cymbalta: (Duloxetine) 60mg for treatment of Depression and DPNP
• Rated during 2008 as High Successful Med. Rep. Hit 101% of 2008 target.*
• Rated during 2009 as Successful Med Rep 15% over 2009 target*
• Rated during 2010 as exemplary medical rep achieving 2% above 2010 sales plan
• Zyprexa Line best Achiever Award 2009*
• APEX winner for 2010 in Argentina* for outstanding sales performence
• Employee of the quarter Q2 2009
• Awards By Lilly:
• Best Production Award During the cycle Meeting in Malaysia 2009.*
• IASEA Award 2009 for the contribution by the team work in achieving an Extra 1 Million USD in the SGH 31 quantities.*
• Symbicort: (Budesonide+formeterol)Turbuhaler device for the management of Asthma
• Rhinocort Aqua: (budesonide) treatment of Allergic Rhinitis and Sinusitis
Successfully passed clinical pharmacy courses tough and evaluated by professors from south Carolina college of pharmacy